17-78901393-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001243540.2(CEP295NL):​c.44+392T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.461 in 239,908 control chromosomes in the GnomAD database, including 27,257 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.49 ( 19210 hom., cov: 31)
Exomes 𝑓: 0.41 ( 8047 hom. )

Consequence

CEP295NL
NM_001243540.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.531

Publications

18 publications found
Variant links:
Genes affected
CEP295NL (HGNC:44659): (CEP295 N-terminal like) Predicted to enable microtubule binding activity. Predicted to be involved in regulation of centriole replication. Predicted to be located in motile cilium. Predicted to be active in centriole; centrosome; and cytosol. [provided by Alliance of Genome Resources, Apr 2022]
TIMP2 (HGNC:11821): (TIMP metallopeptidase inhibitor 2) This gene is a member of the TIMP gene family. The proteins encoded by this gene family are natural inhibitors of the matrix metalloproteinases, a group of peptidases involved in degradation of the extracellular matrix. In addition to an inhibitory role against metalloproteinases, the encoded protein has a unique role among TIMP family members in its ability to directly suppress the proliferation of endothelial cells. As a result, the encoded protein may be critical to the maintenance of tissue homeostasis by suppressing the proliferation of quiescent tissues in response to angiogenic factors, and by inhibiting protease activity in tissues undergoing remodelling of the extracellular matrix. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.647 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001243540.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CEP295NL
NM_001243540.2
MANE Select
c.44+392T>C
intron
N/ANP_001230469.1
TIMP2
NM_003255.5
MANE Select
c.130+23566T>C
intron
N/ANP_003246.1
CEP295NL
NM_001243541.2
c.-192+392T>C
intron
N/ANP_001230470.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CEP295NL
ENST00000322630.3
TSL:2 MANE Select
c.44+392T>C
intron
N/AENSP00000312767.2
TIMP2
ENST00000262768.11
TSL:1 MANE Select
c.130+23566T>C
intron
N/AENSP00000262768.6
CEP295NL
ENST00000590267.6
TSL:2
c.-192+392T>C
intron
N/AENSP00000516640.1

Frequencies

GnomAD3 genomes
AF:
0.490
AC:
74488
AN:
151868
Hom.:
19191
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.653
Gnomad AMI
AF:
0.373
Gnomad AMR
AF:
0.421
Gnomad ASJ
AF:
0.455
Gnomad EAS
AF:
0.270
Gnomad SAS
AF:
0.401
Gnomad FIN
AF:
0.523
Gnomad MID
AF:
0.497
Gnomad NFE
AF:
0.429
Gnomad OTH
AF:
0.477
GnomAD4 exome
AF:
0.409
AC:
35984
AN:
87922
Hom.:
8047
AF XY:
0.406
AC XY:
18948
AN XY:
46720
show subpopulations
African (AFR)
AF:
0.634
AC:
1615
AN:
2546
American (AMR)
AF:
0.393
AC:
1941
AN:
4942
Ashkenazi Jewish (ASJ)
AF:
0.438
AC:
1053
AN:
2406
East Asian (EAS)
AF:
0.241
AC:
1035
AN:
4292
South Asian (SAS)
AF:
0.379
AC:
4668
AN:
12302
European-Finnish (FIN)
AF:
0.461
AC:
1735
AN:
3766
Middle Eastern (MID)
AF:
0.563
AC:
198
AN:
352
European-Non Finnish (NFE)
AF:
0.414
AC:
21679
AN:
52400
Other (OTH)
AF:
0.419
AC:
2060
AN:
4916
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
988
1977
2965
3954
4942
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
204
408
612
816
1020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.490
AC:
74547
AN:
151986
Hom.:
19210
Cov.:
31
AF XY:
0.493
AC XY:
36608
AN XY:
74288
show subpopulations
African (AFR)
AF:
0.653
AC:
27080
AN:
41460
American (AMR)
AF:
0.421
AC:
6415
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.455
AC:
1576
AN:
3466
East Asian (EAS)
AF:
0.269
AC:
1390
AN:
5166
South Asian (SAS)
AF:
0.401
AC:
1932
AN:
4816
European-Finnish (FIN)
AF:
0.523
AC:
5513
AN:
10544
Middle Eastern (MID)
AF:
0.486
AC:
143
AN:
294
European-Non Finnish (NFE)
AF:
0.429
AC:
29152
AN:
67968
Other (OTH)
AF:
0.477
AC:
1007
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1865
3730
5594
7459
9324
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
658
1316
1974
2632
3290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.445
Hom.:
54880
Bravo
AF:
0.490
Asia WGS
AF:
0.339
AC:
1181
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
4.3
DANN
Benign
0.34
PhyloP100
0.53
PromoterAI
0.011
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2889529; hg19: chr17-76897475; API